Anders Liljeblad

Anders Liljeblad discloses dealings in Prostatype Genomics AB to Finansinspektionen. In total, 3 filings cover trades dated 31 August 2026.

Purchases make up the whole of the open-market record (3 purchases, €51k). No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

On 31 August 2026 came the latest disclosure, an open-market purchase for €51k in Prostatype Genomics AB. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.